COVID-19 reduced U.S. life expectancy, especially among Black and Latino populations
University of Southern California
The researchers project that, due to
the pandemic deaths last year, life expectancy at birth for Americans will
shorten by 1.13 years to 77.48 years, according to their study published
Thursday in the Proceedings of the National Academy of Sciences.
That is the largest single-year
decline in life expectancy in at least 40 years and is the lowest life
expectancy estimated since 2003.
The declines in life expectancy are likely even starker among minority populations. For Blacks, the researchers project their life expectancy would shorten by 2.10 years to 72.78 years, and for Latinos, by 3.05 years to 78.77 years.
Whites are also impacted, but their
projected decline is much smaller -- 0.68 years -- to a life expectancy of
77.84 years.
Overall, the gap in life expectancy
between Blacks and whites is projected to widen by 40%, from 3.6 to more than 5
years -- further evidence of the disease's disparate impact on disadvantaged
populations.
"Our study analyzes the effect of this exceptional number of deaths on life expectancy for the entire nation, as well as the consequences for marginalized groups," said study author Theresa Andrasfay, a postdoctoral fellow at the USC Leonard Davis School of Gerontology.
"The COVID-19 pandemic's disproportionate effect on the life
expectancy of Black and Latino Americans likely has to do with their greater exposure
through their workplace or extended family contacts, in addition to receiving
poorer health care, leading to more infections and worse outcomes."
COVID-19 appears to have eliminated
many of the gains made in closing the Black-white life expectancy gap since
2006. Latinos, who have consistently experienced lower mortality than whites --
a phenomenon known as the "Latino paradox" -- would see their more
than three-year survival advantage over whites reduced to less than one year.
"The huge decline in life
expectancy for Latinos is especially shocking given that Latinos have lower
rates than the white and Black populations of most chronic conditions that are
risk factors for COVID-19," said study co-author Noreen Goldman, the
Hughes-Rogers Professor of Demography and Public Affairs at the Princeton
School of Public and International Affairs. "The generally good health of
Latinos prior to the pandemic, which should have protected them from COVID-19,
has laid bare the risks associated with social and economic disadvantage."
The study's authors estimated life
expectancy at birth and at age 65 for 2020 for the total U.S. population and by
race and ethnicity. They used four scenarios of deaths -- one in which the
COVID-19 pandemic had not occurred and three others that include COVID-19
mortality projections by the Institute for Health Metrics and Evaluation, an
independent global health research center at the University of Washington.
"The bigger reductions in life
expectancy for the Black and Latino populations result in part from a
disproportionate number of deaths at younger ages for these groups,"
Goldman said. "These findings underscore the need for protective behaviors
and programs to reduce potential viral exposure among younger individuals who
may not perceive themselves to be at high risk."
Life expectancy as an indicator of
population health
Of the analyzed deaths for which
race and ethnicity have been reported to the National Center for Health
Statistics, 21% were Black and 22% Latino. Black and Latino Americans have
experienced a disproportionate burden of coronavirus infections and deaths,
reflecting persistent structural inequalities that heighten risk of exposure to
and death from COVID-19.
The researchers say life expectancy
is an important indicator of a population's health and an informative tool for
examining the impact of COVID-19 on survival.
In the decades before the COVID-19
pandemic, annual improvements in U.S. life expectancy had been small but
overall life expectancy had rarely declined. An exception was the annual
reduction of 0.1 year for three consecutive years -- 2015, 2016, and 2017 --
which were attributed in part to increases in so-called "deaths of despair"
among middle-aged whites related to drug overdoses, including opioids, as well
as alcohol-related liver disease and suicide.
The projected pandemic-related drop
in life expectancy is about 10 times as large as the declines seen in recent
years.
The last major pandemic to
significantly reduce life expectancy in a short period of time was the 1918
influenza pandemic, which research indicates reduced life expectancy by an
extraordinary 7-12 years.
As of Wednesday, more than 10
million Americans had received their first COVID-19 vaccination dose, according
to the U.S. Centers for Disease Control and Prevention. But the vaccines may
not be enough to immediately reverse the impact of the disease on U.S. life
expectancy.
"While the arrival of effective
vaccines is hopeful, the U.S. is currently experiencing more daily COVID-19
deaths than at any other point in the pandemic," Andrasfay said.
"Because of that, and because we expect there will be long-term health and
economic effects that may result in worse mortality for many years to come, we
expect there will be lingering effects on life expectancy in 2021."
"That said," she added,
"no cohort may ever experience a reduction in life expectancy of the
magnitude attributed to COVID-19 in 2020."
The study authors say they are now
studying occupational exposures to COVID-19 by race and ethnicity to further
comprehend its disproportionate impact.
The research was supported by the
National Institute on Aging (grant number T32AG000037).
